AstraZeneca Pharma India Limited (ASTRAZEN.NS)
INR 8062.25
(2.46%)
INR 8062.25
(2.46%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.47 Billion INR | -44.33% |
| 2022 | 4.94 Billion INR | 30.55% |
| 2021 | 3.78 Billion INR | 4.62% |
| 2020 | 3.61 Billion INR | -8.38% |
| 2019 | 3.94 Billion INR | -1.84% |
| 2018 | 4.02 Billion INR | 28.38% |
| 2017 | 3.13 Billion INR | 1.05% |
| 2016 | 3.1 Billion INR | -1.36% |
| 2015 | 3.14 Billion INR | 8.69% |
| 2014 | 2.89 Billion INR | -8.64% |
| 2013 | 3.16 Billion INR | 6.92% |
| 2012 | 2.96 Billion INR | -7.87% |
| 2011 | 3.21 Billion INR | 2.78% |
| 2010 | 3.12 Billion INR | 83.08% |
| 2009 | 1.7 Billion INR | 31.13% |
| 2008 | 1.3 Billion INR | 15.29% |
| 2007 | 1.12 Billion INR | -40.38% |
| 2006 | 1.89 Billion INR | 20.18% |
| 2005 | 1.57 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 580.5 Million INR | -6.8% |
| 2023 Q3 | 1.46 Billion INR | 4.5% |
| 2023 Q4 | 622.82 Million INR | -57.38% |
| 2023 Q1 | 1.21 Billion INR | -6.93% |
| 2023 FY | 2.75 Billion INR | -44.33% |
| 2023 Q2 | 1.39 Billion INR | 15.17% |
| 2022 FY | 4.94 Billion INR | 30.55% |
| 2022 Q4 | 1.3 Billion INR | 3.54% |
| 2022 Q1 | 1.25 Billion INR | 93.48% |
| 2022 Q2 | 1.12 Billion INR | -10.66% |
| 2022 Q3 | 1.26 Billion INR | 12.31% |
| 2021 Q2 | 1.03 Billion INR | 5.84% |
| 2021 Q4 | 649.08 Million INR | -41.9% |
| 2021 FY | 3.78 Billion INR | 4.62% |
| 2021 Q1 | 980.63 Million INR | 70.11% |
| 2021 Q3 | 1.11 Billion INR | 7.63% |
| 2020 Q2 | 1 Billion INR | 3.88% |
| 2020 FY | 3.61 Billion INR | -8.38% |
| 2020 Q1 | 970.09 Million INR | 28.85% |
| 2020 Q4 | 576.48 Million INR | -45.78% |
| 2020 Q3 | 1.06 Billion INR | 5.49% |
| 2019 Q3 | 1.1 Billion INR | 4.88% |
| 2019 Q4 | 752.91 Million INR | -31.9% |
| 2019 Q2 | 1.05 Billion INR | 1.76% |
| 2019 Q1 | 1.03 Billion INR | 16.19% |
| 2019 FY | 3.94 Billion INR | -1.84% |
| 2018 Q2 | 975.45 Million INR | -4.7% |
| 2018 Q4 | 891.51 Million INR | -21.23% |
| 2018 FY | 4.02 Billion INR | 28.38% |
| 2018 Q1 | 1.02 Billion INR | 7.8% |
| 2018 Q3 | 1.13 Billion INR | 16.02% |
| 2017 Q2 | 789.03 Million INR | -1.16% |
| 2017 FY | 3.13 Billion INR | 1.05% |
| 2017 Q4 | 949.54 Million INR | -9.28% |
| 2017 Q3 | 1.04 Billion INR | 32.66% |
| 2017 Q1 | 798.26 Million INR | -0.94% |
| 2016 Q1 | 814.41 Million INR | 18.39% |
| 2016 Q4 | 805.82 Million INR | -3.09% |
| 2016 FY | 3.1 Billion INR | -1.36% |
| 2016 Q2 | 928.16 Million INR | 13.97% |
| 2016 Q3 | 831.51 Million INR | -10.41% |
| 2015 Q3 | 832.98 Million INR | -7.09% |
| 2015 Q2 | 896.58 Million INR | 23.51% |
| 2015 Q1 | 725.94 Million INR | 216.24% |
| 2015 Q4 | 687.87 Million INR | -17.42% |
| 2015 FY | 3.14 Billion INR | 8.69% |
| 2014 Q3 | 838.93 Million INR | -7.89% |
| 2014 Q1 | 912.67 Million INR | 24.9% |
| 2014 Q2 | 910.8 Million INR | -0.2% |
| 2014 FY | 2.89 Billion INR | -8.64% |
| 2014 Q4 | 229.55 Million INR | -72.64% |
| 2013 FY | 3.16 Billion INR | 6.92% |
| 2013 Q2 | 803.8 Million INR | -3.05% |
| 2013 Q1 | 829.05 Million INR | 16.97% |
| 2013 Q3 | 801.84 Million INR | -0.24% |
| 2013 Q4 | 730.69 Million INR | -8.87% |
| 2012 FY | 2.96 Billion INR | -7.87% |
| 2012 Q4 | 708.75 Million INR | -13.82% |
| 2012 Q3 | 822.41 Million INR | 5.35% |
| 2012 Q2 | 780.62 Million INR | 4.97% |
| 2012 Q1 | 743.63 Million INR | -20.77% |
| 2011 FY | 3.21 Billion INR | 2.78% |
| 2011 Q3 | 842.44 Million INR | 0.0% |
| 2011 Q4 | 938.56 Million INR | 11.41% |
| 2010 FY | 3.12 Billion INR | 83.08% |
| 2009 FY | 1.7 Billion INR | 31.13% |
| 2008 FY | 1.3 Billion INR | 15.29% |
| 2007 FY | 1.12 Billion INR | -40.38% |
| 2006 FY | 1.89 Billion INR | 20.18% |
| 2005 FY | 1.57 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aarti Drugs Limited | 1.16 Billion INR | -111.867% |
| Albert David Limited | 1.02 Billion INR | -141.047% |
| Alembic Limited | 872.45 Million INR | -183.509% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -36168.328% |
| Hester Biosciences Limited | 908.84 Million INR | -172.16% |
| Hikal Limited | 4.46 Billion INR | 44.588% |
| Ind-Swift Limited | 946.56 Million INR | -161.313% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -499.742% |
| Unichem Laboratories Limited | 6.72 Billion INR | 63.224% |
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 84.414% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -442.928% |
| Bajaj HealthCare Limited | 985.34 Million INR | -151.029% |
| Brooks Laboratories Limited | 51.18 Million INR | -4732.943% |
| Eris Lifesciences Limited | 4.94 Billion INR | 49.959% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | 3.156% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -464.018% |
| Wanbury Limited | 978.96 Million INR | -152.665% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | 19.545% |
| Alkem Laboratories Limited | 32.83 Billion INR | 92.467% |
| FDC Limited | 3.49 Billion INR | 29.324% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | 78.751% |
| Gufic Biosciences Limited | 1.18 Billion INR | -108.455% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -16.445% |
| Innova Captab Limited | 931.03 Million INR | -165.674% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -12.381% |
| Ipca Laboratories Limited | 18.98 Billion INR | 86.973% |
| Jubilant Pharmova Limited | 14.45 Billion INR | 82.887% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -130.267% |
| Lupin Limited | 125.09 Billion INR | 98.023% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -1424.706% |
| Medico Remedies Limited | 59.67 Million INR | -4044.952% |
| Morepen Laboratories Limited | 1.98 Billion INR | -24.456% |
| Nectar Lifesciences Limited | 932.7 Million INR | -165.198% |
| Orchid Pharma Limited | 800.77 Million INR | -208.89% |
| Procter & Gamble Health Limited | 2.99 Billion INR | 17.423% |
| RPG Life Sciences Limited | 1.63 Billion INR | -51.238% |
| Sigachi Industries Limited | 579.88 Million INR | -326.549% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 98.396% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -76.327% |
| Themis Medicare Limited | 1.12 Billion INR | -119.711% |
| Vaishali Pharma Limited | 84.02 Million INR | -2843.627% |
| Venus Remedies Limited | 1.91 Billion INR | -29.078% |
| Windlas Biotech Limited | 1 Billion INR | -145.75% |
| ZIM Laboratories Limited | 1.01 Billion INR | -144.162% |
| Sakar Healthcare Limited | 204.07 Million INR | -1112.031% |
| Aurobindo Pharma Limited | 55.65 Billion INR | 95.556% |
| Divi's Laboratories Limited | 14.17 Billion INR | 82.544% |
| Mankind Pharma Limited | 29.27 Billion INR | 91.55% |
| Sequent Scientific Limited | 2.9 Billion INR | 14.76% |
| Laurus Labs Limited | 11.9 Billion INR | 79.231% |
| Neuland Laboratories Limited | 2.92 Billion INR | 15.573% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 83.279% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 94.732% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 98.025% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -18.121% |
| Wockhardt Limited | 8.48 Billion INR | 70.831% |
| Bal Pharma Limited | 555.62 Million INR | -345.174% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 97.42% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -74.286% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -4143.582% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -13.75% |
| Shilpa Medicare Limited | 3.33 Billion INR | 25.814% |
| Valiant Laboratories Limited | 138.02 Million INR | -1692.015% |
| Ajanta Pharma Limited | 30.46 Billion INR | 91.88% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -17303.082% |
| Granules India Limited | 10.31 Billion INR | 76.015% |
| Medicamen Biotech Limited | 335.16 Million INR | -637.99% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -615.643% |
| Piramal Enterprises Limited | 63.65 Billion INR | 96.114% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 88.454% |
| NATCO Pharma Limited | 10.05 Billion INR | 75.408% |
| Suven Life Sciences Limited | 109.75 Million INR | -2153.759% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -5259.0% |
| Strides Pharma Science Limited | 9.16 Billion INR | 73.004% |
| Indoco Remedies Limited | 12.06 Billion INR | 79.492% |
| Alpa Laboratories Limited | 127.38 Million INR | -1841.828% |
| Lasa Supergenerics Limited | 291.17 Million INR | -749.492% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 19.608% |